Intravenous Amantadine for Freezing of Gait Resistant to Dopaminergic Therapy: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Clinical Trial

BACKGROUND: Freezing of gait (FOG) is one of the most disabling symptoms in Parkinsonism. Open-label studies have suggested that intravenous (IV) amantadine is effective against FOG resistant to dopaminergic therapy in Parkinson's disease (PD). We evaluated the efficacy of IV amantadine on FOG...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kim, Young Eun, Yun, Ji Young, Yang, Hui June, Kim, Han-Joon, Gu, Namyi, Yoon, Seo Hyun, Cho, Joo-Youn, Jeon, Beom S.
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2012
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3501515/
https://ncbi.nlm.nih.gov/pubmed/23185280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0048890
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы